Quantitative CT Measurements of Interstitial Lung Disease: Same-Day Variability Between Two Vendors-A Prospective Study.
Authors
Affiliations (5)
Affiliations (5)
- Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
- Department of Biomedical Engineering, AMIST, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Convergence Medicine, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Bigdata Research Center, Asan Institute for Life Science, Asan Medical Center, Seoul, Republic of Korea.
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract
<b>Background:</b> Clinical application of quantitative CT (QCT) measurements of interstitial lung disease (ILD) for longitudinal monitoring of disease progression requires understanding of how such measurements vary across vendors. <b>Objective:</b> To evaluate same-day variability between vendors for QCT measurements of fibrosis extent in patients with ILD. <b>Methods:</b> This prospective study recruited participants with diagnosed ILD from January 2023 to August 2024. Participants underwent two serial nonenhanced chest CT examinations on the same day using GE and Siemens scanners, separated by approximately 15 minutes. Examinations were reconstructed using three kernels (GE: LUNG, BONE, CHEST: Siemens: B60f, B50f, B30f); LUNG and B60f represented each vendor's primary high-frequency kernel for ILD evaluation. Commercially available deep-learning-based software was used for QCT analysis. The fibrosis score was calculated as the sum of reticular opacity and honeycombing volume percentages. Intervendor variability was assessed using the Bland-Altman method; agreement was assessed using the concordance correlation coefficient (CCC). <b>Results:</b> The study included 48 participants (mean age, 67.8±5.2 years; 43 male, 5 female). The mean fibrosis score for the LUNG and B60f kernels was 12.64% and 11.84%, respectively. For the fibrosis score, the mean raw difference ranged from a minimum for the BONE-B50f kernel pair (0.11%; 95% limits of agreement [LOA]: -1.3% to 1.5%) to a maximum for the LUNG-B30f kernel pair (-2.52%; 95% LOA: -6.5% to 1.4%). The LUNG-B60f kernel pair showed a mean raw difference of -0.80% (95% LOA: -3.4% to 1.8%). The 95% LOA was narrowest for the BONEB50f kernel pair and widest for the LUNG-B30f kernel pair. The fibrosis score demonstrated substantial to almost perfect agreement across all intervendor kernel combinations (CCC, 0.953-0.998), including almost perfect agreement for the LUNG-B60f kernel pair (CCC, 0.989). <b>Conclusion:</b> QCT-derived fibrosis scores showed small variability (mean raw difference, 0.8%) for same-day CT examinations performed using systems from two different vendors when reconstructed with each vendor's primary high-frequency kernel for lung evaluation. <b>Clinical impact:</b> QCT-derived fibrosis scores across different vendors may be informative for longitudinal ILD assessment when interpreted in the context of expected measurement variability.